Contact US

Geoff Muckle was born in 1977 in Johannesburg, South Africa. Following vocational studies in theology and psychology in Cape Town, he moved to England where he began a sales and marketing career in the pharmaceutical industry. Geoff climbed the commercial ladder in pharmaceuticals, gaining experience and expertise in the oncology sector across multiple management roles including leading Roche’s personalised oncology account management strategy across the pharma, diagnostics and R&D organisations. Having grown a passion for personalised medicine, he joined Champions Oncology in 2014 where alongside driving contract translational research across Europe, he successfully led the commercialisation of two personalised oncology solutions in the UK: the Champions TumourGraft, an in vivo drug-sensitivity testing platform, and the Caris Molecular Profiling test, a multi-platform molecular profiling technology. Geoff became the CEO of Imagen Therapeutics in 2018, focusing the company on developing it’s predictRx test, and implementing a clinical validation and commercialisation strategy.

 

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Spotify
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound
Contact Us

© Copyright 2022 Imagen Therapeutics Ltd